Lack of interaction between thioctic acid, glibenclamide and acarbose
- Author
- GLEITER, C. H1 ; SCHREEB, K. H1 ; HERMANN, R1 ; FREUDENTHALER, S1 ; THOMAS, M1 ; ELZE, M2 ; FIEGER-BÜSCHGES, H2 ; POTTHAST, H2 ; SCHNEIDER, E3 ; SCHUG, B. S2 ; BLUME, H. H2
[1] Abteilung Klinische Pharmakologie, Universität Göttingen, Göttingen, Germany
[2] Zentrallaboratorium Deutscher Apotheker, Eschborn, Germany
[3] Department of Clinical Pharmacology, Corporate Research, ASTA Medica AG, Frankfurt, Germany - Conference title
- British Pharmacological Society and Deutsche Geselleschaft für experimentelle und klinische Pharmakologie und Toxikologie. Joint Meeting
- Conference name
- British Pharmacological Society and Deutsche Geselleschaft für experimentelle und klinische Pharmakologie und Toxikologie. Joint Meeting (Nottingham 1999-07-14)
- Author (monograph)
- British Pharmacological Society, United Kingdom (Funder/Sponsor)
Deutsche Geselleschaft für experimentelle und klinische Pharmakologie und Toxikologie, Germany (Funder/Sponsor) - Source
British journal of clinical pharmacology. 1999, Vol 48, Num 6, pp 819-825 ; ref : 15 ref
- CODEN
- BCPHBM
- ISSN
- 0306-5251
- Scientific domain
- Pharmacology drugs
- Publisher
- Blackwell Science, London
- Publication country
- United Kingdom
- Document type
- Conference Paper
- Language
- English
- Keyword (fr)
- 1,2-Dithiolane-3-valérique acide Acarbose Association médicamenteuse Dose unique Enantiomère Glibenclamide Glycémie Homme Hypoglycémiant Individu sain Inhibiteur enzyme Insuline Interaction médicamenteuse Pharmacocinétique Stéréosélectivité Sulfonylurées Voie orale α-Glucosidase Enzyme Glycosidases Hydrolases O-Glycosidases
- Keyword (en)
- Thioctic acid Acarbose Drug combination Single dose Enantiomer Glibenclamide Glycemia Human Hypoglycemic agent Healthy subject Enzyme inhibitor Insulin Drug interaction Pharmacokinetics Stereoselectivity Sulfonylureas Oral administration α-Glucosidase Enzyme Glycosidases Hydrolases O-Glycosidases
- Keyword (es)
- Tióctico ácido Acarbosa Asociación medicamentosa Dosis única Enantiómero Glibenclamida Glucemia Hombre Hipoglicemiante Individuo sano Inhibidor enzima Insulina Interacción medicamentosa Farmacocinética Estereoselectividad Sulfonilureas Vía oral α-Glucosidase Enzima Glycosidases Hydrolases O-Glycosidases
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02O Hormones. Endocrine system
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 1218418
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1046/j.1365-2125.1999.00097.x 
https://dx.doi.org/10.1046/j.1365-2125.1999.00097.x
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1046\/j.1365-2125.1999.00097.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:69:\"Lack of interaction between thioctic acid, glibenclamide and acarbose\";s:9:\"\u0000*\u0000jtitle\";s:40:\"British journal of clinical pharmacology\";s:9:\"\u0000*\u0000stitle\";s:22:\"Br. j. clin. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"48\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"819\";s:8:\"\u0000*\u0000epage\";s:3:\"825\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0306-5251\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"GLEITER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:13:\"SCHREEB, K. H\";i:1;s:10:\"HERMANN, R\";i:2;s:16:\"FREUDENTHALER, S\";i:3;s:9:\"THOMAS, M\";i:4;s:7:\"ELZE, M\";i:5;s:19:\"FIEGER-B\u00dcSCHGES, H\";i:6;s:11:\"POTTHAST, H\";i:7;s:12:\"SCHNEIDER, E\";i:8;s:11:\"SCHUG, B. S\";i:9;s:11:\"BLUME, H. H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BCPHBM\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:137:\"British Pharmacological Society and Deutsche Geselleschaft f\u00fcr experimentelle und klinische Pharmakologie und Toxikologie. Joint Meeting\";s:8:\"\u0000*\u0000title\";s:69:\"Lack of interaction between thioctic acid, glibenclamide and acarbose\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Blackwell Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1046\/j.1365-2125.1999.00097.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:69:\"Lack of interaction between thioctic acid, glibenclamide and acarbose\";s:9:\"\u0000*\u0000jtitle\";s:40:\"British journal of clinical pharmacology\";s:9:\"\u0000*\u0000stitle\";s:22:\"Br. j. clin. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"48\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"819\";s:8:\"\u0000*\u0000epage\";s:3:\"825\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0306-5251\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"GLEITER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:13:\"SCHREEB, K. H\";i:1;s:10:\"HERMANN, R\";i:2;s:16:\"FREUDENTHALER, S\";i:3;s:9:\"THOMAS, M\";i:4;s:7:\"ELZE, M\";i:5;s:19:\"FIEGER-B\u00dcSCHGES, H\";i:6;s:11:\"POTTHAST, H\";i:7;s:12:\"SCHNEIDER, E\";i:8;s:11:\"SCHUG, B. S\";i:9;s:11:\"BLUME, H. H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BCPHBM\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:137:\"British Pharmacological Society and Deutsche Geselleschaft f\u00fcr experimentelle und klinische Pharmakologie und Toxikologie. Joint Meeting\";s:8:\"\u0000*\u0000title\";s:69:\"Lack of interaction between thioctic acid, glibenclamide and acarbose\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Blackwell Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:32:\"10.1046\/j.1365-2125.1999.00097.x\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1046\/j.1365-2125.1999.00097.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:69:\"Lack of interaction between thioctic acid, glibenclamide and acarbose\";s:9:\"\u0000*\u0000jtitle\";s:40:\"British journal of clinical pharmacology\";s:9:\"\u0000*\u0000stitle\";s:22:\"Br. j. clin. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"48\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"819\";s:8:\"\u0000*\u0000epage\";s:3:\"825\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0306-5251\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"GLEITER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:13:\"SCHREEB, K. H\";i:1;s:10:\"HERMANN, R\";i:2;s:16:\"FREUDENTHALER, S\";i:3;s:9:\"THOMAS, M\";i:4;s:7:\"ELZE, M\";i:5;s:19:\"FIEGER-B\u00dcSCHGES, H\";i:6;s:11:\"POTTHAST, H\";i:7;s:12:\"SCHNEIDER, E\";i:8;s:11:\"SCHUG, B. S\";i:9;s:11:\"BLUME, H. H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BCPHBM\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:137:\"British Pharmacological Society and Deutsche Geselleschaft f\u00fcr experimentelle und klinische Pharmakologie und Toxikologie. Joint Meeting\";s:8:\"\u0000*\u0000title\";s:69:\"Lack of interaction between thioctic acid, glibenclamide and acarbose\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Blackwell Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1046\/j.1365-2125.1999.00097.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:69:\"Lack of interaction between thioctic acid, glibenclamide and acarbose\";s:9:\"\u0000*\u0000jtitle\";s:40:\"British journal of clinical pharmacology\";s:9:\"\u0000*\u0000stitle\";s:22:\"Br. j. clin. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"48\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"819\";s:8:\"\u0000*\u0000epage\";s:3:\"825\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0306-5251\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"GLEITER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:13:\"SCHREEB, K. H\";i:1;s:10:\"HERMANN, R\";i:2;s:16:\"FREUDENTHALER, S\";i:3;s:9:\"THOMAS, M\";i:4;s:7:\"ELZE, M\";i:5;s:19:\"FIEGER-B\u00dcSCHGES, H\";i:6;s:11:\"POTTHAST, H\";i:7;s:12:\"SCHNEIDER, E\";i:8;s:11:\"SCHUG, B. S\";i:9;s:11:\"BLUME, H. H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BCPHBM\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:137:\"British Pharmacological Society and Deutsche Geselleschaft f\u00fcr experimentelle und klinische Pharmakologie und Toxikologie. Joint Meeting\";s:8:\"\u0000*\u0000title\";s:69:\"Lack of interaction between thioctic acid, glibenclamide and acarbose\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Blackwell Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1046\/j.1365-2125.1999.00097.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:69:\"Lack of interaction between thioctic acid, glibenclamide and acarbose\";s:9:\"\u0000*\u0000jtitle\";s:40:\"British journal of clinical pharmacology\";s:9:\"\u0000*\u0000stitle\";s:22:\"Br. j. clin. pharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"48\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"819\";s:8:\"\u0000*\u0000epage\";s:3:\"825\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0306-5251\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"GLEITER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:13:\"SCHREEB, K. H\";i:1;s:10:\"HERMANN, R\";i:2;s:16:\"FREUDENTHALER, S\";i:3;s:9:\"THOMAS, M\";i:4;s:7:\"ELZE, M\";i:5;s:19:\"FIEGER-B\u00dcSCHGES, H\";i:6;s:11:\"POTTHAST, H\";i:7;s:12:\"SCHNEIDER, E\";i:8;s:11:\"SCHUG, B. S\";i:9;s:11:\"BLUME, H. H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BCPHBM\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:137:\"British Pharmacological Society and Deutsche Geselleschaft f\u00fcr experimentelle und klinische Pharmakologie und Toxikologie. Joint Meeting\";s:8:\"\u0000*\u0000title\";s:69:\"Lack of interaction between thioctic acid, glibenclamide and acarbose\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Blackwell Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
